For USA readers – Protect Our Department of Defense Prostate Cancer Funding

UPDATE June &, 2016 4:30 PM EST We won. The Durbin Amendment to save all cancer research funding at the Department of Defense passed 66-32, saving the Congressionally Directed Medical Research Program (CDMRP), which includes an important prostate cancer funding resource. Thank you to everyone from Malecare Cancer Support and all of our partner organizations for sending in your emails and making your phone calls. Three cheers for you! To see how your Senators voted on this important matter go to the bottom of this post.  If your Senator voted YEA send an email thanking them.  However, if they voted [...]

By | June 2nd, 2016|DOD, DOD PCRP, Politics of Cancer, United States|0 Comments

Good News, The House Appropriations Committee Increases the Ask For The DoD PCRP Allocation for FY 2017

Today, I have some good news to share with you. Malecare, along with many other prostate cancer advocacy groups have been hard at work attempting to persuade members of Congress to not only maintain the Department of Defense Prostate Cancer Research Program (DoD PCRP), but to increase its funding for the next fiscal year. I am happy to report that we have successfully made the first, vital step towards accomplishing our goal! We have just found out that the congressional appropriators have recommend that Congress increases by $10 million fiscal year 2017 funding level. The U.S. House of Representatives' Committee [...]

U.S. Congress Passes Omnibus Funding with Significant Increases for Medical Research

We have some good news, the United States Congress has passed the Omnibus spending package.  The package will fund the U.S. Government through fiscal 2016.  We should take note that this bill includes a $2 billion increase for the National Institute of Health (NIH), a 5% increase for the National Cancer Institute (NCI) and the Food and Drug Administration (FDA).  The bill also includes funding for the Department of Defense Medical Research Program with an allocation of $80 million for the Prostate Cancer Research Program. My only disappointment is that the DOD PCRP (Prostate Cancer Research Program) didn't receive additional [...]

By | December 20th, 2015|advocacy, DOD PCRP, FDA, NCI, NIH, Politics of Cancer, Uncategorized, United States|0 Comments
スーパーコピーブランド ロレックススーパーコピー オメガスーパーコピー ブルガリスーパーコピー ブライトリングスーパーコピー カルティエスーパーコピー シャネル時計コピー IWCスーパーコピー フランクミュラースーパーコピー パネライスーパーコピー タグホイヤースーパーコピー ウブロスーパーコピー ガガミラノスーパーコピー ルイヴィトンスーパーコピー シャネルスーパーコピー エルメススーパーコピー グッチスーパーコピー ボッテガヴェネタスーパーコピー プラダスーパーコピー セリーヌスーパーコピー ロレックススーパーコピー ウブロスーパーコピー